BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 36738459)

  • 1. Impact of salvage surgery with or without reirradiation for skull base meningiomas recurring after prior radiotherapy.
    Rubino F; Schur S; McGovern SL; Kamiya-Matsuoka C; DeMonte F; Raza SM
    J Neurosurg; 2023 Sep; 139(3):798-809. PubMed ID: 36738459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skull base atypical meningioma: long term surgical outcome and prognostic factors.
    Wang YC; Chuang CC; Wei KC; Hsu YH; Hsu PW; Lee ST; Wu CT; Tseng CK; Wang CC; Chen YL; Jung SM; Chen PY
    Clin Neurol Neurosurg; 2015 Jan; 128():112-6. PubMed ID: 25486076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term surgical outcome and biological prognostic factors in patients with skull base meningiomas.
    Ohba S; Kobayashi M; Horiguchi T; Onozuka S; Yoshida K; Ohira T; Kawase T
    J Neurosurg; 2011 May; 114(5):1278-87. PubMed ID: 21166572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of radiotherapy and stereotactic radiosurgery as adjuvant or salvage treatment in atypical and anaplastic (WHO grade II and III) meningiomas: a systematic review and meta-analysis.
    Gagliardi F; De Domenico P; Snider S; Pompeo E; Roncelli F; Barzaghi LR; Acerno S; Mortini P
    Neurosurg Rev; 2023 Mar; 46(1):71. PubMed ID: 36928326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgically resected skull base meningiomas demonstrate a divergent postoperative recurrence pattern compared with non-skull base meningiomas.
    Mansouri A; Klironomos G; Taslimi S; Kilian A; Gentili F; Khan OH; Aldape K; Zadeh G
    J Neurosurg; 2016 Aug; 125(2):431-40. PubMed ID: 26722844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resection and permanent intracranial brachytherapy using modular, biocompatible cesium-131 implants: results in 20 recurrent, previously irradiated meningiomas.
    Brachman DG; Youssef E; Dardis CJ; Sanai N; Zabramski JM; Smith KA; Little AS; Shetter AG; Thomas T; McBride HL; Sorensen S; Spetzler RF; Nakaji P
    J Neurosurg; 2018 Dec; 131(6):1819-1828. PubMed ID: 30579269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningioma.
    El Shafie RA; Czech M; Kessel KA; Habermehl D; Weber D; Rieken S; Bougatf N; Jäkel O; Debus J; Combs SE
    Radiat Oncol; 2018 May; 13(1):86. PubMed ID: 29739417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiologic Response and Disease Control of Recurrent Intracranial Meningiomas Treated With Reirradiation.
    Lin AJ; Hui C; Dahiya S; Lu HC; Kim AH; Campian JL; Tsien C; Zipfel GJ; Rich KM; Chicoine M; Huang J
    Int J Radiat Oncol Biol Phys; 2018 Sep; 102(1):194-203. PubMed ID: 29970312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-irradiation for recurrent intracranial meningiomas: Analysis of clinical outcomes and prognostic factors.
    Desideri I; Morelli I; Banini M; Greto D; Visani L; Nozzoli F; Caini S; Della Puppa A; Livi L; Perini Z; Zivelonghi E; Bulgarelli G; Pinzi V; Navarria P; Clerici E; Scorsetti M; Ascolese AM; Osti MF; Anselmo P; Amelio D; Minniti G; Scartoni D
    Radiother Oncol; 2024 Jun; 195():110271. PubMed ID: 38588920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant radiotherapy for atypical meningiomas.
    Bagshaw HP; Burt LM; Jensen RL; Suneja G; Palmer CA; Couldwell WT; Shrieve DC
    J Neurosurg; 2017 Jun; 126(6):1822-1828. PubMed ID: 27611201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of adjuvant radiotherapy after subtotal resection for WHO grade I meningioma: a propensity score matching analysis of the Brain Tumor Registry of Japan.
    Oya S; Ikawa F; Ichihara N; Wanibuchi M; Akiyama Y; Nakatomi H; Mikuni N; Narita Y
    J Neurooncol; 2021 Jun; 153(2):351-360. PubMed ID: 34002302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.
    Rogers L; Zhang P; Vogelbaum MA; Perry A; Ashby LS; Modi JM; Alleman AM; Galvin J; Brachman D; Jenrette JM; De Groot J; Bovi JA; Werner-Wasik M; Knisely JPS; Mehta MP
    J Neurosurg; 2018 Jul; 129(1):35-47. PubMed ID: 28984517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of postoperative radiotherapy on recurrence of primary intracranial atypical meningiomas.
    Keric N; Kalasauskas D; Freyschlag CF; Gempt J; Misch M; Poplawski A; Lange N; Ayyad A; Thomé C; Vajkoczy P; Meyer B; Ringel F
    J Neurooncol; 2020 Jan; 146(2):347-355. PubMed ID: 31900826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningioma.
    Lubgan D; Rutzner S; Lambrecht U; Rössler K; Buchfelder M; Eyüpoglu I; Fietkau R; Semrau S
    J Neurooncol; 2017 Sep; 134(2):407-416. PubMed ID: 28667597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skull Base Meningiomas: Is Surgical Resection Enough? Outcome Evaluation and Prognostic Factors Analysis in a Single-Center Cohort.
    Pessina F; Navarria P; Rossini Z; Clerici E; Fornari M; Politi LS; Scorsetti M; Servadei F
    J Neurol Surg A Cent Eur Neurosurg; 2022 Nov; 83(6):516-522. PubMed ID: 34897619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. World Health Organization Grade II Meningiomas: The Role of Adjuvant/Salvage Gamma Knife Surgery After Initial Surgery and Prognostic Factor Assessment.
    Liu X; Shan B; Wang M; Xu J
    World Neurosurg; 2018 Jan; 109():e352-e362. PubMed ID: 28987849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence of cranial base meningiomas.
    Mathiesen T; Lindquist C; Kihlström L; Karlsson B
    Neurosurgery; 1996 Jul; 39(1):2-7; discussion 8-9. PubMed ID: 8805134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining the role of adjuvant radiotherapy in the management of meningioma: a Surveillance, Epidemiology, and End Results analysis.
    Reddy AK; Ryoo JS; Denyer S; McGuire LS; Mehta AI
    Neurosurg Focus; 2019 Jun; 46(6):E3. PubMed ID: 31153148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Outcomes of Newly Diagnosed Resected Atypical Meningiomas and the Role of Adjuvant Radiotherapy.
    Zhi M; Girvigian MR; Miller MJ; Chen JC; Schumacher AJ; Rahimian J; Lodin K
    World Neurosurg; 2019 Feb; 122():e1153-e1161. PubMed ID: 30447464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk group-adapted adjuvant radiotherapy for WHO grade I and II skull base meningioma.
    Park S; Cha YJ; Suh SH; Lee IJ; Lee KS; Hong CK; Kim JW
    J Cancer Res Clin Oncol; 2019 May; 145(5):1351-1360. PubMed ID: 30953136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.